𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epstein-Barr Virus load and immune activation in Human Immunodeficiency Virus type 1-infected patients

✍ Scribed by Maria Raffaella Petrara; Anna Maria Cattelan; Marisa Zanchetta; Lolita Sasset; Riccardo Freguja; Ketty Gianesin; Maria Grazia Cecchetto; Francesco Carmona; Anita De Rossi

Book ID
116632248
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
420 KB
Volume
53
Category
Article
ISSN
1386-6532

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quantification of Epstein-Barr virus loa
Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR
✍ Axelle Dehee; Catherine Asselot; Tristan Piolot; Christine Jacomet; Willy Rozenb 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 1 views

## Abstract Epstein‐Barr virus (EBV) reactivation is more likely to occur in immunocompromised patients with subsequent higher susceptibility to EBV‐associated lymphoproliferations. In contrast to transplant recipients, limited data are available concerning the EBV load in HIV‐infected patients, wi

Induction of Epstein-Barr virus in B-lym
Induction of Epstein-Barr virus in B-lymphoblastoid cells by human immunodeficiency virus type 1
✍ Patrick K. Lai; Xu Li; David J. Volsky 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 861 KB

Individuals infected with the human immunodeficiency virus (HIV), the etiologic agent of acquired immunodeficiency syndrome (AIDS), often show symptoms associated with reactivation of Epstein-Barr virus (EBV). In this study, we show that exposure of EBV-positive B lymphocytes to HIV-I in vitro induc

Epstein-Barr virus and human immunodefic
Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART
✍ Cathal E. O'Sullivan; RongSheng Peng; Kelly Stefano Cole; Ronald C. Montelaro; T 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract Epstein‐Barr virus (EBV) associated non‐Hodgkin lymphoma is recognized as a complication of human immunodeficiency virus (HIV) infection. Little is known regarding the influence of highly active antiretroviral therapy (HAART) on the biology of EBV in this population. To characterize the